Thromb Haemost 1997; 77(06): 1223
DOI: 10.1055/s-0038-1656146
Letters to the Editor
Schattauer GmbH Stuttgart

Severe Bleeding due to Factor V Inhibitor after Repeated Operations Using Fibrin Sealant Containing Bovine Thrombin

W Muntean
1   Department of Pediatrics, Divs.of General Pediatrics, University of Graz, Austria
,
W Zenz
1   Department of Pediatrics, Divs.of General Pediatrics, University of Graz, Austria
,
G Edlinger
1   Department of Pediatrics, Divs.of General Pediatrics, University of Graz, Austria
,
A Beitzke
2   Department of Pediatrics, Divs.of Pediatric Cardiology, University of Graz, Austria
› Author Affiliations
Further Information

Publication History

Received 27 January 1997

Accepted after revision 06 March 1997

Publication Date:
12 July 2018 (online)

 
  • References

  • 1 Carrol JF, Moskowitz KA, Edwards NM, Hickley TJ, Rose EA, Budzynski AZ. Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent. Thromb Haemost 1996; 76: 925-931
  • 2 Zehnder JL, Leung LLK. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990; 76: 2011-2016
  • 3 Muntean W, Zenz W, Finding K, Zobel G, Beitzke A. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child. Acta Pediatr 1994; 84: 84-87